Analyticon Biotechnologies AG

Analyticon® Biotechnologies AG manufactures tests for human medical diagnosis, with approx. 83 employees in two facilities in the North of Hesse in Germany.



Our philosophy:

Quality is our profession

has caught on also outside Germany:



Based on a worldwide network of dealers and branch offices, we are distributing our products all over the world, meeting the requirements of the German Medical Product Law and the RiliBÃ?K as well as the standards of the US Food and Drug Administration (FDA) and the Chinese inspectorate SFDA.



All Products are manufactured in line with the GMP and DIN ISO 13 485 rules. We guarantee for a complete quality control, covering development, production and sales.



Analyticon´s R&D continuously expands its product portfolio and at the same time keeps the quality of its IVD product offer at the highest level by regular product enhancements and perfective maintenance. The main activities are in line with Analyticon´s core competence in the field of rapid tests which are focussing on the development of new point of care tests (POCTs) for their use by medical professionals and POCTs for self-/home testing, as strips and dipsticks. The envisaged biomarkers cover a broad range of clinical applications:



Pregnancy tests

Ovulation tests

Diabetes

Cardiac markers

Tumor markers

Infectious diseases

Drugs of abuse tests





The tests under development are based on a proprietary methodology using synthetic nucleic acids or other comparable docking molecules as highly specific binders for individual biomarkers which act as molecular switches depending on the presence or absence of the respective marker molecule. This methodology, for which Analyticon® has filed patent, promises technical and economic advantages for POCT tests compared to the products that are currently available in the IVD market without accepting